Filter

41 - 50 of 296 Results

  • The Outlook for PEPFAR in 2025 and Beyond

    Policy Watch

    PEPFAR, the U.S. global HIV/AIDS program, is - for the first time in its two-decade history - facing significant challenges that could impede its ability to fulfill its mission. This policy brief provides an overview of recent events and ongoing challenges facing the program.

  • How Much Global Health Funding Goes Through USAID?

    Policy Watch

    This analysis highlights USAID's role in global health and shows that the agency provided the vast majority of the nation's global health assistance for other countries in 2023 (about $6.2 billion or 73% of the total bilateral global health funding that year).

  • A Look at Federal Health Data Taken Offline

    Policy Watch

    This post looks at federal government databases with key health data that went offline on Jan. 31, 2025, including several related to HIV, some of which had returned by Feb. 2, 2025. It briefly describing the affected databases, which include widely used, large-scale national health surveys, indices, and data dashboards, that inform research, policy making, and media coverage about health care and public health.

  • Section 1115 Waiver Watch: A Look at the Use of Contingency Management to Address Stimulant Use Disorder

    Policy Watch

    Contingency management is an evidence-based psychosocial intervention that uses motivational incentives, such as vouchers or gift cards, to encourage recovery behaviors like stimulant abstinence and treatment session (e.g., cognitive behavioral therapy, group therapy) attendance. The Biden administration has approved five state contingency management waivers (California, Delaware, Hawaii, Montana, and Washington); two additional state contingency management requests are currently pending federal review.

  • What’s Next for State Abortion Ballot Initiatives?

    Policy Watch

    This brief examines what the November election and prior efforts to enshrine abortion rights at the ballot box mean for those states and what’s next, including the future of abortion restrictions in states where voters enshrined abortion rights where abortion was banned or restricted, as well as those that do not have abortion bans.

  • How HHS, FDA, and CDC Can Influence U.S. Vaccine Policy

    Policy Watch

    This policy brief highlights areas in which HHS, FDA, and CDC have authority to shape U.S. vaccine policy with a specific focus on vaccine approvals and recommendations for the public. Ultimately, while there are limits, federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and vaccine use in the U.S. However, this does not include imposing mandates on or changing local vaccination requirements, as those authorities rest with state and local governments.